GSMA's latest update on coronavirus

GSMA's latest update on coronavirus

Coronavirus can’t spread if the patient doesn’t have symptoms, report says As previously stated, the GSMA has implemented many measures to help to mitigate the spread of the virus and is continuing to add other actions regularly. In particular, there are additional health measures that have been put in place which include; A free 24-hour telephone Security and Medical service for all attendees, operational from 12-29 February 2020. This number appears on the back of badge holders, in the event App and on signage around the venue: +34 900 77 2020 Hygiene recommendations to Barcelona hotels, public and private transport, restaurants and catering outlets, etc. The GSMA has reinforced the on-site first aid facilities to assist attendees Developed plans in alignment with the Public Health Authority Services which are subject to medical and health authority approval. The GSMA is building on its existing plans to protect the health of our attendees, clients and staff at MWC Barcelona. Colleagues around the world are taking active measures to contain and lessen any further spread of the virus. These measures include adhering to advice from the WHO and other health authorities, respecting travel restrictions where they exist, arriving early in Spain to allow time for self-quarantine and ensuring access to masks. Up-to-date WHO advice and facts can be found here: www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance . Further updates from the GSMA, answers to the most frequently asked questions and an outline of the measures that have been implemented, are on our website and can be found on www.mwcbarcelona.com . Source:



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More